Table 4. Composition of the 16S–23S ribosomal ISR in clinical samples containing TPA DNA.
| Clinical sample | 16S–23S ISR (rrn1/rrn2) | Genotype* | Subtype† |
| 2K | Ile/Ala | SU2R8 | 14d |
| 4K | Ile/Ala | SSS | 14d |
| 6K | Ile/Ala | SSS | 14d |
| 15K | Ile/Ala | SSS | 14d |
| 24K | Ile/Ala | SSS | 14d |
| 27K | Ile/Ala | SSS | 14d |
| 34K | Ile/Ala | SSS | 14d |
| 40K | Ile/Ala | SSR8 | 14d |
| 44K | Ile/Ala | SSS | 14d |
| 47K | Ile/Ala | SSS | 12d |
| 49K | Ile/Ala | SSR8 | 14d |
| 51K | Ile/Ala | SSS | 14d |
| 52K | Ile/Ala | SSS | 14d |
| 53K | Ile/Ala | SSS | 14d |
| 63K | Ile/Ala | SSR9 | 15d |
| 73K | Ile/Ala | SU2R8 | 14d |
| 91K | Ile/Ala | SSS | 14d |
| 6000 | Ile/Ala | SU2R8 | 14d |
| 9888 | Ile/Ala | SSS | 14d |
| 14048 | Ile/Ala | SSS | 14d |
| 14207 | Ile/Ala | SSS | 14d |
| 16142 | Ile/Ala | SU2R8 | 14d |
| RL86Z | Ile/Ala | SU2R8 | 14d |
| RL89BZ | Ile/Ala | SSS | 14d |
| RL95B | Ile/Ala | SSS | 14d |
| RL102B | Ile/Ala | SSS | 14d |
| RL104B | Ile/Ala | SU2R8 | 14d |
| RL110B | Ile/Ala | SSS | 14d |
| RL111B | Ile/Ala | SU2R8 | 14d |
| RL116A | Ile/Ala | XXR8 | 14e |
*
Identified according to the method of Flasarová et al. (2012).
†
Subtype according to the method of Pillay et al. (1998).